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Ability to induce specific  unresponsiveness against selected  antigens in adult, immu- 
nocompetent individuals is a long desired goal in transplantation  immunology.  In the 
clinic it is based on the realization that heterogeneity  of man  with regard to major 
histocompatibility  antigens  is so great that the likelihood of obtaining  completely 
matched grafts between nonsiblings is very small. Thus, successful grafting of organs 
today between human beings does normally involve various degrees of  ~acceptable" misfit 
as to histocompatibility matching. Treatment of  the recipient  with immunosuppressive 
drugs is  therefore necessary. Such drug therapy is  largely nonselective and is  well  known 
to have a variety of detrimental side effects  as to the health of the recipient. In the 
present article  we will  describe an approach that would seem to carry great hope as to 
allow specific  induction of immune  tolerance in adult individuals towards the major 
histocompatibility antigens of  the species. 
The reasoning behind this approach goes as follows:  The genes coding for  the antigen- 
binding receptors of B and/or T lymphocytes allow the construction of antigen-binding 
areas reactive with foreign as well as "self"-structures.  Reactivity against self  is fre- 
quently controlled and prevented at several different  levels,  but can be circumvented in 
many instances. Among  the self-structures  against which autoimmunity can be induced 
are the actual antigen-binding receptor structures themselves  (1).  Thus, it has been 
possible  to  induce auto-anti-idiotypic  immunity against receptors of  either B- (2)  or  T-cell 
(3, 4) type. Such anti-receptor immunity may have varying effects  depending upon the 
idiotypic system analyzed. In one such system it could be shown that if  the receptors 
against which autoimmunity was induced carried specificity  for a given set of  histocom- 
patibility  antigens the outcome would be specific  transplantation tolerance (3,  5).  In  these 
earlier  experiments there was a requirement for availability  of  anti-idiotypic  reagents to 
purify the soluble,  idiotypic  receptor material subsequently to  be  used as autoimmunogen 
(3, 5). Such antisera would be close  to impossible to obtain in the hypothetical clinical 
situation, as they would have to be made against the recipient's  own receptors with 
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specificity for the potential donor's HLA antigens. Realizing this,  we have attempted 
another,  similar approach  with more general applicability if successful.  This system 
concentrates on the actual physical isolation of the idiotype-positive cells in a pure form, 
to subsequently  be used as autoimmunogen  to induce anti-idiotypic  immunity. Normal T 
cells as well as T lymphoblasts specifically activated in mixed leukocyte culture (MLC)  I 
express idiotypic receptors signifying reactivity against the relevant histocompatibility 
antigen. They are normally found in a few percent in the normal population (6-10) but 
can be  greatly expanded via proliferation in MLC  (II).  During expansion the  small 
lymphocytes will enlarge to lymphoblasts and such cells can now be recovered in purified 
form  via  1 g  velocity sedimentation procedures  (12).  It turns out that  such  specific, 
purified T lymphoblasts in adjuvant will constitute a powerful autoimmunogen  leading to 
specific unresponsiveness  as well as production of auto-anti-idiotypic  antibodies (present 
article and reference 12). 
The present article will describe the general validity of this autoblast immu- 
nization approach as to species and histocompatibility barriers and will discuss 
the theoretical and practical implications. 
Materials and Methods 
Animals 
MICE.  Mice of the inbred strains CBA/J,  CBA/H,  C3H/HeJ,  A/J,  DBA/2J,  BALB/cJ,  and 
C57BL/6J were purchased from The Jackson Laboratory, Bar Harbor, Maine, or bred in part in our 
own colony. Mice of uniform sex at the age of 5-8 wk were used for the experiments. 
RATS.  Rats of the inbred strains Lewis (Ag-BI), DA (Ag-B4), BN (Ag-Ba), and August (Ag-B  s) 
were bred and maintained  in our own colony. Rats at the age of 6-10 wk of either sex were used in 
the experiments. 
GUINEA PIGS.  Outbred guinea pigs were purchased from a local breeder. 
Cell Preparations.  Spleen and lymph node cells  were  aseptically removed and single cell 
suspensions were prepared with a  stainless steel mesh using Dulbecco's  modified  phosphate- 
buffered saline (D-PBS)  as  a  medium.  Cells were washed once  and erythrecytes were  lysed 
thereafter by hypotonic shock using nine parts of distilled water and one part of 10 times D-PBS. 
Cells were washed again and rosuspended in the culture medium. 
Peripheral blood lymphocytes were purified on a Ficoll-Paque (Pharmacia Fine Chemicals Ltd., 
Uppsala, Sweden). Isolated lymphocytes were washed throe times in culture medium before tissue 
culture or tests. T lymphocytes as responder cells in MLCs were produced  using anti-Ig bead 
columns (13). 
Culture Medium.  The culture medium used for MLC and cell-mediated lympholysis (CML) 
both for rats and mice was EHAA medium (14), complemented with 0.5% fresh normal mouse 
serum for mice and 0.5-1% of fresh BN rat serum for rats. Guinea pig lymphocytes were cultured 
in RPMI 1640 medium complemented with 5% fetal calf serum (FCS). 
MLC.  MLCs for mice, rats, and guinea pigs were performed  in fiat-bottom microtiter plates 
(Cook M220-29ART), using 0.25  x  104 responder lymphocytes and 0.5  x  10  e 2,000 R irradiated 
stimulator cells.  For the culture medium see above.  Cultures were pulsed for 5 h with 1 ~tCi of 
tritiated thymidine (SH-TdR) (sp act 40-60 Ci/mmol; The Radiochemical Centre, Amersham, UK) 
before the harvesting as indicated in tables and figures. Cultures were harvested using a Skatron 
collector (Skatron, AS, 3401 Lierbyen, Norway) and counted in a liquid scintillation  counter. 
For the preparation of large quantities of specific lymphoblasts in MLC cells were cultured in 
flasks (Falcon 3013 Tissue Culture Flasks; Falcon Plastics, Div. of Becton-Dickinson  & Co., Ltd., 
Drogheda,  Ireland) using the same medium as described above. 15 ml of cell suspensions contain- 
ing 1.25 x  10  e responder cells and 2.5 × 10  e 2,000 R irradiated stimulator cells/m1 were added to 
1  Abbreviations  used in this paper: CML, cell-mediated lympholysis; D-PBS, Dulbecco's modi- 
fied phosphate-buffered saline; FCS, fetal calf serum; aH-TdR, tritiated thymidine; MLC, mixed 
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each flask.  Cultures were harvested on day 5 after initiation of the MLC for mice and guinea 
pigs and on day 6 for rats. 
CML.  CML was performed in V-bottom microtiter plates in 200 ~tl of EHAA medium supple- 
mented with 5% heat-inactivated FCS. Assays were carried out in triplicates or quadruplicates. 
Each well contained 1  x  10  e or 5  x  105 effector cells and 1  x  10  ~ 51Cr-labeled target cells. Plates 
were incubated for 6 h  at 37°C  in 5% CO~ in air.  Maximum release figures were determined by 
adding 100 ~1 of 0.4% Nonidet P-40 detergent.  Percent cytotoxicity (% CML) is expressed as: 
experimental -  spontaneous 51Cr release 
100  x 
maximum -  spontaneous 5~Cr release. 
The following target cell~ were used: For 11-2  ~, El-4; for H-2 d, P-815. 
Purification  of T  Lymphoblasts  from  MLC.  MLC  were  pooled  in  50-ml  Falcon tubes  and 
centrifuged for 10 min at 400 g. Cells were pooled and washed again in D-PBS and resuspended in 
D-PBS containing 5% FCS. Cells were then applied on a linear 15-30% FCS gradient (15) using D- 
PBS as  diluent.  The gradient was  harvested after 4-5 h  at 4°C  in  15-ml tubes and the blast 
fractions (determined under the microscope) pooled and washed four times in 50-ml Falcon tubes. 
The fractions containing small, MLC nonreactive lymphocytes were handled in exactly the same 
way. 
Immunization of Animals with Purified T Lymphoblasts.  As routine procedure each animal 
received i  x  107 (mouse) or 2 x  107 (rat) purified T lymphoblasts in 0.2 ml of D-PBS and Freund's 
adjuvant  intraperitoneally.  For  the  first  injection complete  Freund's  adjuvant  was  used  and 
incomplete Freund's adjuvant for the boosters. Animals received one, two, three, or four injections 
in 3-wk intervals and were bled 10-14 days after the last injection. One guinea pig was injected 
four times in 3-wk intervals with 1.5  x  10  e purified T lymphoblasts in Freund's adjuvant. 
Results 
Autoimmunization  against  Autologous  Lymphoblasts  Cause Specific  Unre- 
sponsiveness against the Relevant AUoantigens.  A pilot experiment to test for 
the validity of the principle  was first carried out.  Adult,  normal  CBA/J mice 
were thus immunized with purified specific syngeneic T lymphoblasts created in 
MLC  against  C57BL/6  stimulator  cells.  Each  mouse  received  10  ~ blasts  per 
immunization  event. The animals  were immunized thrice,  the first time with 
the blasts in Freund's complete adjuvant, followed by blasts in Freund's incom- 
plete adjuvant in 3-wk intervals. Results of the two mice depicted in Fig. 1 show 
the procedure to be a successful one with close to complete specific reduction in 
MLC against the relevant stimulator cells.  Third-party  reactivity was hardly 
touched.  Thus,  autoimmunization  with  specific  MLC  blasts  can  be  used  to 
achieve specific unresponsiveness against major histocompatibility antigens in 
adult mice, thus confirming preliminary,  earlier data (12). 
Definition of  Histocompatibility  Barriers and Species where Autoblast Immu- 
nization  Will Lead to Specific  Unresponsiveness 
ACROSS MAJOR HISTOCOMPATIBILITY,  I-1-2,  BARRIERS  IN THE MOUSE.  In order to 
establish the conditions during  which the present autoblast conditions can be 
shown to function with regard to species as well as across different histocompati- 
bility barriers  within  a  species several sets of experiments  were carried  out. 
Here, we first extended the above analysis to include a variety of mouse strain 
combinations all known to encompass the major locus, H-2, as a barrier. Figs. 2- 
4  depict  additional  combinations  showing  autoblasts  to  function  as  specific 
suppressive  agents  using  the  schedule  described  above.  Table  I  adds  more 
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Fro.  1.  Specific unresponsiveness of autoimmunized CBA/J mice against C57BL/6 alloan- 
tigens  as  measured  in  MLC.  MLC  was  performed  in  flat-bottom  microtiter  plates  as 
described under Material and Methods.  Mice were injected three times in 3-wk intervals 
with purified CBA/J anti-C57BL/6 MLC T  lymphoblasts  (see Material and Methods)  and 
tested  10  days after the last  injection.  Columns represent  mean  ±  SE of quadruplicate 
cultures of purified T lymphocytes (T cells were purified on Ig-anti-Ig columns). (1) Normal 
CBA/J mouse, and (2) and (3) auteimmunized CBA/J mice. (a) Response against C57BL/6 
stimulater cells, (b) response against DBA/2J reaponder cells, and (c) responder cells alone. 
Cultures were pulsed for 6 h with I  pCi of 3H-TdR and harvested 96 h aider initiation of the 
MLC. 
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FIe.  2.  Induction of specific suppression of proliferative response by autoimmunization. 
CBA/J mice were autoimmunized as described for Fig. 1 and tested 10 days after the last 
injection. Each point represents mean of triplicate cultures which were pulsed for 6 h with 1 
/~Ci ofaH-TdR. Two additional animals treated in the very same way gave similar results. 1128  T  LYMPHOBLASTS  AND  SPECIFIC  IMMUNE 
cpm 
)OOZe0. 
r~000, 
~pO0. 
~OpO0. 
mop00. 
SOpO0. 
t~t  OOAo2 
ClA~ 
......  .  9OA#2~ 
c~m 
300,000. 
zso~ooo. 
UNRESPONSIVENESS 
D1~12  ~o~d  w~  t)O~2 
c~  eI.£ blo-.~ 
zoopoo. 
~oo,ooo.  ~  a~ 
~o~oo.  .¢~ 
~t  ~  ~  N  120  ~t  ~  ~  48  T/  I  ~0  W~t 
FxG.  3.  DBA/2 mice were i~ected four times in 3-wk intervals with purified DBA/2 anti- 
C3H MLC T lymphobla~s and their spleen cells were tested in MLC 10 days ai~r the last 
injection in comparison to normal DBA/2 mice. MLC was performed in micretiter plates as 
described under Material and Methods. 
t~U'$ 
the specific unresponsiveness caused by the autoblast immunization, leaving 
third-party reactivity unperturbed. Autoblast immunization procedures would 
thus seem to function across probably any H-2 barriers. It has to be noticed that 
lymphocytes from  autoimmunized mice  respond  significantly stronger  than 
normal lymphocytes to normal syngeneic stimulator cells. We don't know the 
exact reason behind this phenomenon. Preliminary experiments indicate that 
both purified B as well as purified T lymphocytes serving as stimulator cells can 
induce the proliferation. 
ACROSS M LOCUS BARRIERS IN THE MOUSE.  The M  locus in the mouse repre- 
sents a  genetic system, distinct from the H-2  system (16). M  locus-determined 
structures can function as specific triggering antigens for a high proportion of 
normal, M locus-incompatible T cells in MLC in vitro and can thus be tested in 
the present system. In Figs. 5 and 6 are shown the typical results obtained using 
MLC blasts from reciprocal strains identical as to H-2 but different as to M locus 
antigens. As seen, the pattern observed seemed identical to those found when 
using anti-H-2 autoblasts as immunogen. Thus, specific unresponsiveness with 
regard to the relevant M locus incompatibility was induced by blast immuniza- 
tion with no evidence of nonspecific reduction as to third-party antigens. Auto- 
blast immunization can thus be shown to function across M locus differences in 
the mouse. 
ACROSS THE  MAJOR HISTOCOMPATIBILITY,  Ag-B, BARRIER IN THE  RAT.  Specific 
unresponsiveness against Ag-B-incompatible stimulator cells [including multi- 
ple,  non-Ag-B  barriers  as  well  (17)] could be  induced in  Ag-B-incompatible 
strain  combinations  in  the  rat  using  the  autoblast  immunization protocol. 
Results of such tests are shown in Table II, depicting close to complete elimina- 
tion of reactivity in several individuals with again no detectable impact as to 
third-party reactivity. Autoblast immunization can thus be shown to function in 
the rat across major histocompatibility barriers. ANDERSSON,  AGUET,  WIGHT,  ANDERSSON,  BINZ,  AND  WIGZELL  1129 
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FIG. 4.  Mice of  the inbred strain  A were immunized four times in 3-wk intervals  with 
either  purified  A anti-BALB/c MLC T lymphoblasts  or  purified  A anti-BALB/c MLC small, 
nonresponder  lymphocytes. Their  spleens  were  tested  10  days  after  the  last  injection  against 
irradiated  stimulator cells  as indicated.  For MLC  see Material and Methods. 
TABLE  I 
Specific Induction of Unresponsiveness  in CBA/H Mice Immunized with CBA/H-Anti- 
DBA/2 T Lymphoblasts 
Autoimmunized donor*  DBA/2 stimulator  A.BY stimulator cells* 
cells* 
%  % 
1  87  -3 
2  48  11 
3  67  18 
4  30  -21 
5  76  6 
6  85  9 
Mean percent inhibition  65  3 
* Spleen  cells  from  individual  CBA/H autoblast-immunized  mice  analyzed  in  MLC. Cells  obtained 
after  three injections  of  10  z  lymphoblasts 3 wk apart.  MLC harvested at  day 4. 
* Results presented as  percent inhibition  as  compared to  control  values = 0% inhibition  = values 
obtained using spleen cells  from normal CBA/H mice. NOrmel  CIA  CBA  *mmunile,  d  with  CBA-~C3H 
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FIG.  5.  CBA/J mice were immunized four times in 3-wk intervals with purified CBA/J 
anti-C3H MLC T lymphoblasts and their spleen cells were tested in MLC 10 days atter the 
last injection. Conditions as described in legend to Fig. 3. 
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FIG.  6.  C3H mice were injected four times with purified C3H anti-CBA MLC T lympho- 
blasts. Conditions otherwise as in legend to Fig. 5. 
ACROSS  "MLC  BARRIERS"  IN  OUTBRED  GUINEA  PIGS.  In  this  test  we  used 
outbred guinea pigs and are thus ignorant as to the exact histocompatibility 
differences involved. The guinea pigs were selected, however, to differ from each 
other in a three-way manner as measured by primary MLC tests. Accordingly, 
we assume that these tested guinea pigs have distinct differences at their major 
histocompatibility locus. Three outbred guinea pigs were thus tested in MLC 
before choosing one as the "prospective recipient" and another as stimulator of 
autoblasts. Blasts for autoimmunization were obtained as depicted in Material 
and Methods, and the immunization protocol was carried out as shown in Table 
III. The results were very clear-cut. A complete elimination of MLC reactivity 
against the relevant guinea pig was induced by the autochthonous blasts with ANDERSSON,  AGUET,  WIGHT,  ANDERSSON,  BINZ,  AND  WIGZELL  1131 
TABLE II 
Specific Unresponsiveness Across AgB-Locus Barrier in Lewis Rats Immunized with Purified 
Lewis-Anti-DA T Lymphoblasts 
Stimulator cells$ 
No. of  rats  blast  immunized*  (Lewis x BN)F,  (Lewis x DA)F~  O 
Day 4  Day 6  Day 4  Day 6  Day 4  Day 6 
%  %  %  %  %  % 
1  100  86  15  8  136  129 
2  93  79  l0  9  90  103 
3  98  126  15  10  199  110 
4  125  104  11  16  81  90 
5  108  129  12  7  222  95 
6  91  Iii  8  II  109  118 
Mean  relqmMe  of  normal  7,785 _+ 146  14,309  ±  817  12,660 ±  1,066  25,448 ±  1,709  389 ±  19  303 ± 37 
Lewis spleens (cpm +- SB) 
* Spleen cells from individual Lewis rats immunized with Lewis-anti-DA blasts three times. 
* Stimulation expressed as percent reaction compared to controls. 
TABLE III 
Suppressed Proliferative  Response of Guinea Pig Immunized with Specific T 
L ymphoblasts 
Responder cells 
from guinea pig 
no. 1, before/after 
autoimmuniza- 
tion 
aH-TdR  incorporation  of  3H-TdR  incorporation  of 
mixture  with  guinea  mixture  with  guinea 
pig  stimulator  cell  no.  pig  stimulator  cell  no. 
2, mean cpm of  tripli-  3, mean cpm of  tripli- 
cates  _+ SE  cates +- SE 
3H-TdR incorporation  of 
responder cells alone, 
mean cpm of triplicates 
-+ SE 
Before  32,351  _+  2,057  29,046  +_ 3,882  1,641  _+  124 
After  2,338  _+  205  24,485  _+  1,100  2,688  -+  183 
Outbred guinea-pig no. I was immunized four times with I anti-2 MLC lymphoblasts (see Material 
and Methods). Cultures were pulsed for 6 h with I/zCi of 3H-TdR 110 h affair initiation of the MLC. 
no effect as to MLC  reactivity against the third guinea pig. We  can thus 
conclude that the autoblast immunization  protocol does also lead to specific 
unresponsiveness  in yet another species, the guinea pig. The results do also 
demonstrate that it  is  practically possible to obtain enough lymphocytes from a 
donor to  use in  MLC  activation and subsequently serve as efficient  autoimmuno- 
gen in the form of  purified lymphoblasts. 
Analysis of MLC Factors that Can Be Used to Obtain Specific Unresponsive- 
ness: Purified  T  Lymphoblasts  are  the Best Immunogens.  Based  on earlier 
experiments and recent studies we consider auto-anti-idiotypic immunity to be 
the most likely explanation as to what is causing the specific unresponsiveness 
induced via autoblast immunization  (12).  However, in the present protocol we 
assume that alloantigen as well as idiotypic material may play a role. Idiotypic 
receptor material in a  soluble form can be found in the  MLC  Supernates  (12). 
Alloantigen  can be detected both in a  soluble form and frequently also on the 
surface of activated MLC blasts (18).  To ensure that our principle reasoning as 
to the necessity of purified T  lymphoblasts would be true we thus investigated 
whether concentrated MLC supernates or small nonresponding lymphocytes in 
MLC  can be used  as  autoimmunogen  instead  of the  purified  lymphoblasts.  A 1132  T  LYMPHOBLASTS  AND  SPECIFIC  IMMUNE  UNRESPONSIVENESS 
summary of our results obtained using such approaches is shown in Table IV. 
As seen, the only positive outcome as to achieve specific unresponsiveness was 
obtained using the purified lymphoblasts. 
In the same table are depicted some approaches ofnsing pure lymphoblasts in 
absence of any adjuvant or attempting several forms of adjuvant treatment.  As 
seen,  only the  scheme  using  Freund's  adjuvant  plus  blasts  was  found to  be 
efficient  in  inducing  unresponsiveness.  We  have  thus  decided  to  follow the 
scheme outlined in the very first paragraph in the Results sections until other 
protocols have been shown to be functioning  (see also Discussion). 
Kinetics of  Induction of Unresponsiveness: Influence of  Dose of  Blasts Admin- 
istered and Time after Immunization.  The number of blasts required as well 
as  time  after  immunization  necessary  for  induction  of unresponsiveness  to 
become significant are questions of practical importance in the present system. 
An extensive protocol would be required to study these problems in detail. Such 
a detailed analysis has, due to lack of sufficient mice, not yet been carried out, 
but several preliminary results of interest have been obtained. We would thus 
conclude  from  our  gathered  experience  so  far  that  already  at  14  days  (the 
earliest time after blast immunization we have tested in some individuals) there 
may exist partial  although  significant  immune suppression.  We have not yet 
attempted  to speed up this  reaction by repeated administration  of autoblasts 
within a short time period. As to dose of blasts required we have failed to induce 
specific immune responsiveness in the mouse across H-2 barriers in experiments 
using 10  e blasts per dose whereas a 10-fold higher dose of the same blast cells has 
resulted in close to complete suppression. We know that repeated doses of blasts 
undoubtedly result in a  more efficient depletion of immune specific reactivity 
compared to a  single shot of immunization.  However, a  single  immunization 
may if time is allowed to pass result in a significant reduction. In Table V are 
some results  indicated as to  the number of  blast immunizations used in relation 
to  immune suppression achieved. Finally, reduced reactivity  once established in 
an individual has so far never been found to revert, maybe indicating a self- 
recruiting, suppressive system (see  also  Discussion). 
Parallel Reduction of MLC Reactivity and Cytolytic Killer Cell Activity after 
Autoblast Immunization.  MLC reactivity as well as the dominating  cellular 
cytolytic activity against H-2-incompatible cells are considered to be caused by 
immunocompetent T lymphocytes. T lymphocytes reactive in MLCs are consid- 
ered to represent another subpopulation of immunocompetent T cells than those 
acting as cytolytic killer cells (19).  In the mouse there is also good evidence to 
indicate that the major, H-2-associated target structures for the two groups of 
cells are different:  the MLC-reactive cells predominantly  reacting against  Ia- 
associated antigens while the cytolytic T cells prime targets would be the H-2K 
or D  region structures (20, 21). As the present autoblast immunization protocol 
may or may not include, both subgroups of lymphocytes as efficient, immuno- 
genic blasts we wanted to analyze the impact on cytolytic T cells after autoblast 
immunization procedures. Blast immunizations using mouse or rat strain com- 
binations  differing  with regard  to  MHC  antigens  were used.  MLC  and  CML 
were carried out at different time intervals using responder cells from normal or 
blast-immunized  animals.  In four different combinations tested (CBA/H-anti- ANDERSSON,  AGUET,  WIGHT,  ANDERSSON,  BINZ,  AND  WIGZELL  1133 
TABLE  IV 
Purified L ymphoblasts from MLC in Freund's Adjuvant are the only Inducers of  Specific 
Unresponsiveness 
No. 
of 
Immunogen  Strain combination  . .  Adjuvant 
injec- 
tions 
No. 
sup- 
pressed/ 
total 
MLC supernate 200 x concentrated 
# 
n 
l0  T Small MLC lymphocytes 
10  + Unseparated MLC cells 
101 Separated MLC blasts 
n 
2 x  l0  T Separated MLC blasts 
2 x  l0  T Unseparated MLC cells 
2  x  107 Separated MLC blasts 
CBA/H anti-C57BL/6  2  None 
CBA/H anti-C57BL/6  2  FCA 
CBA/H anti-DBA/2  2  None 
CBA/H anti-DBA/2  2  FCA 
CBA/H anti-DBA/2  2  FCA 
"  2  FCA 
"  2  FCA 
"  2  None 
"  2  FICA 
C57BL/6 anti-CBA  3  Bordetella 
russia 
C57BL/6 anti-CBA  3  None 
Lewis anti-DA  3  CFA 
Lewis anti-DA  3  CFA 
Lewis anti-BN  3  CFA 
per- 
0/4 
0/4 
0/4 
0/3 
0/8 
0/4 
10/12 
0/4 
1/3 
0/4 
0/4 
4/4 
2/4 
3/3 
MLCs were performed as described under Material and Methods. Animals were tested 10-14 days 
after the last injection. 
TABLE V 
Specific Suppression of MLC in Relation to the Dose of  lmmunogen and Immunization 
Frequency 
Strain combination 
Tested  Reactivity compared to normal 
No. of  animals (mean of two mice) 
Dose of MLC  .  .  after 
blasts  lnjec-  last  in- 
tions  jection  Against  Against  Against 
CBA/J  C57BL/6  DBA/2 
CBA/J anti-C57BL/6 
C57BL/6 anti-CBA/J 
days  %  %  % 
1 x  I0  e  2  14  107.0  101.0 
5  x  10  e  2  14  95.8  92.2 
1 ×  107  2  14  19.8  87.8 
1.5  x  10  T  2  14  16.1  87.7 
lx  107  1  14  27.3  92.1 
lx  l0  T  2  14  12.9  78.1 
1×  107  3  14  8.9  74.1 
lx  107  4  14  6.8  73.5 
C57BL/6  anti-CBA/J  1 ×  107  3  90  14.2  71.3 
lx  l0  T  3  300  15.3  87.4 
Mice were injected with purified MLC T lymphoblasts in 3-wk intervals with the dose indicated. 
Blasts were administered in Freund's adjuvant (see Material and Methods). MLC was performed 
in micretiter plates as described under Material and Methods. Cultures were pulsed for 6 h with 1 
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TABLE VI 
A  Relative Comparison between Suppression of MLC vs. CML Activity in Autoblast- 
Immunized CBA/H Mice 
Autoblast immunization* 
MLC suppression~  CML suppression~ 
Anti-H-2  d  Anti-H.2  b  Anti-H-2  d  Anti-H-2  b 
%  %  % 
Anti-H.2  d  71  21  63  0 
Anti-H-2  d  93  7  100  14 
Anti-H-2  d  83  26  58  47 
Anti-H-2  b  0  89  11  72 
% 
* Individual CBA/H mice immunized thrice with 107 CBA/H anti-DBA/2 or CBA/H anti-C57BL/6 
blasts, respectively. 
Percent reduction of activity compared to mean control values (=  100%). 
DBA/2,  CBA/H-anti-C57BL/6,  C57BL/6-anti-DBA/2,  and  Lewis-anti-DA)  the 
results were close to identical, that is MLC and cytolytic activity were reduced 
in a  specific manner and largely in a  parallel manner. Table VI shows one of 
several experiments of  that kind, where responder cells from individual animals 
were compared as to ability to react in MLC and cytolytic assays. As seen, a 
striking positive correlation exists between the degree of specific depletion in 
the two kind of assays. In an additional series of  experiments (data not shown) a 
comparison was made between the number of blast cells present in the MLCs at 
the time of  harvesting and the cytolytic  efficiency. Whereas the number of  blasts 
were specifically reduced (see also DNA synthesis) in the relevant MLCs (the 
actual lytic ability per blast was found normal. Thus, the reduction of cytolytic 
activity achieved via autoblast immunization is not occurring via a  decreased 
lytic activity per killer cell but is more likely due to an actual reduction in the 
number of cytolytic blasts. 
Discussion 
We  present  evidence  that  specific  autoblast  immunization can  lead  to  a 
selective reduction or even complete elimination in immune reactivity against 
the relevant histocompatibility antigens. This induction of immune unrespon- 
siveness could be shown to occur across various histocompatibility barriers and 
we could not detect any species as yet in which the blast immunization would 
fail. It was possible to induce unresponsiveness in outbred individuals using 
their own,  autochthonons blasts  as  immunogen under conditions resembling 
those one would have to use if the present procedure in the future would be 
attempted in the clinical situation. 
The underlying mechanism is not yet understood as to its fine details.  We 
consider the  dominating factor leading to  unresponsiveness to be  auto-anti- 
idiotypic immunity. This, we base on earlier experience when using idiotypic 
receptors in a soluble form as autoimmunogen (3, 5) as well as on the fact that 
autoblast immunization indeed induces auto-anti-idiotypic antibodies (12). As 
such anti-idiotypic antibodies in presence of complement can be shown to be able 
to eliminate in an irreversible manner the relevant immunocompetent lympho- 
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in the present system. The present system does, however, carry as an additional 
complication the possibility of carrying over alloantigen  on the surface of the 
MLC-activated  blasts  (18).  Conceivably,  this  may  lead  to  the  induction  of 
antigen-specific suppressor functioning in an analogous manner to an auto-anti- 
idiotypic immunity.  Although  not finally  excluded,  preliminary  experiments 
carried out so far have failed to indicate the actual existence of suppressor cells 
of such a kind in the autoblast-immunized  animals. 
In the present system reduction in MLC as well as in cytolytic T-cell activity 
occurred  in  parallel  in  the  auto-blast-immunized  animals.  We  don't  know, 
however, whether this means that CML precursor cells have been eliminated. T 
lymphocytes reactive in MLC or developing into killer cells predominantly react 
against different antigenic structures (23). Assuming auto-anti-idiotypic immu- 
nity to be responsible for the present results, one may assume that killer and 
MLC-reactive  cells should carry receptors with  different  idiotopes.  We know 
that cytolytic T cells express idiotypic receptors at the effector stage (22, 23) but 
we have  made no comparison as to distinguish  between idiotypes on the two 
groups  of cells.  It  is  thus  possible that  the  MLC-induced  lymphoblasts  to  a 
predominating degree have contained ~'anti-Ia, idiotype-positive" blasts in a way 
that faulty induction in the blast-immunized animals of anti-idiotypic antibod- 
ies against receptors on CML precursors have occurred. If this was the case, the 
failure  to  develop  CMLs  may  simply  reflect  the  absence  of MLC-reactive 
"helper" cells required for efficient induction of cytotoxic T cells. The necessary 
~three-party" experiments required to test this in the present system have not 
yet been carried out. 
Although still requiring detailed analysis as to optimal conditions, the pres- 
ent  autoblast  immunization  system carries  certain  attractive  features  as  to 
possible clinical application.  Thus,  the induction on unresponsiveness is quite 
specific and, once established, would seem to be very long-lasting.  It is actually 
possible that it will be life long as new idiotype-positive cells being generated 
from stem cells may serve as an inbuilt,  self-maintaining  booster device. Fur- 
thermore,  the number of blasts required in the species investigated are such 
that, using repeated in vitro stimulation,  it is indeed possible to obtain enough 
specific MLC blasts to use autochthonous  blasts as immunogen.  It should be 
stressed, however, that possible problems do also exist.  The dominating hypo- 
thetical  problem  would be the  creation  of immune  complexes  if the  inbuilt 
generation of idiotypic lymphocytes constitutes too powerful a source of antigen. 
Our search so far in the autoblast-immunized animals using conventional tests 
for immune complex damage,  however, have so far been entirely negative but 
we consider it necessary to carry out further tests in this regard to fully exclude 
this possible complication. 
As to the  reason  why autochthonous-purified  T  lymphoblasts can  serve as 
autoantigen  with  regard  to  their  idiotypic receptors,  we can  only speculate. 
Administration of blasts alone or with Bordetella pertussis have failed to induce 
specific suppression. Freund's adjuvant would seem essential in comparison and 
it is well known that such adjuvants may have several pathways of functioning. 
We consider the ability of the adjuvant to cause a  high local concentration  of 
idiotopes an important feature in this regard.  There is also the possibility that 
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proteins onto the surface that could subsequently serve as "carrie~' antigens for 
the idiotypic determinants present on the same cell surface.  We have so far 
never  run  the  velocity sedimentations in  syngeneic  serum  to  exclude  this 
possibility. 
To conclude, we have shown that administration of syngeneic or even autoch- 
thonous-specific lymphoblasts in a pure, immunogenic form will lead to induc- 
tion  of specific  unresponsiveness  against  major histocompatibility antigens. 
This failure to react can be induced in an adult, immunocompetent individual 
without detectable negative side effects so far. The immune unresponsiveness 
once induced would seem long-lasting and does involve at a functional level both 
MLC-reactive T  cells as well as cytolytic T  lymphocytes. The protocol would 
seem to be of  general applicability as it was found to function in all species tested 
and against all histocompatibility barriers analyzed: The potential applications 
of the present procedure in transplantation immunology and delayed hypersen- 
sitivity would seem obvious. 
Summary 
Normal immunocompetent T lymphocytes can be induced into specific prolif- 
eration if confronted with the relevant alloantigen in vitro. Such mixed leuko- 
cyteculture-activated T lymphoblasts carrying idiotypic receptors on their sur- 
face can be purified using velocity sedimentation and serve as immunogen if ad- 
ministered in adjuvant to the autologous host. Autoblast immunization can be 
shown to lead to specific, long-lasting unresponsiveness against the relevant 
alloantigens, while leaving reactivity against third-party antigens intact. When 
tested as to general validity, it could be shown to function in all species analyzed 
(mouse, rat, and guinea pig) as well as across both major and minor histocom- 
patibility barriers. No negative side effects have been noted so far. It would thus 
seem clear that autoblast immunization using the above described scheme may 
serve as a general tool in inducing long-lasting, specific unresponsiveness in any 
species and across any histocompatibility barrier. 
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